Review of Propess- a controlled release dinoprostone (prostaglandin E2 ) pessary

Journal of Obstetrics and Gynaecology

Volumn 17, Issue sup2, 1997, Pages S53-S67

  Calder, A A ^a   Mackenzie, I Z ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIC AGENT; PROSTAGLANDIN E2;

ABDOMINAL PAIN; BACKACHE; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYDROGEL; INTRAVAGINAL DRUG ADMINISTRATION; LABOR INDUCTION; META ANALYSIS; NAUSEA; PARITY; PRIORITY JOURNAL; REVIEW; RISK; TOXIC SHOCK SYNDROME; UTERINE CERVIX DILATATION; VAGINA PESSARY; VOMITING;

EID: 0030842767     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/jog.17.S2.S53     Document Type: Article

References (39)

1. Baravilala W. R., Baker C. and Morsman J. M. (1990) Controlled release prostaglandin E2 pessaries. Lancet, 336, 437.
2. Bex P., Gunasekera P. C. and Phipps J. H. (1990) Difficulties with controlled release prostaglandin E2. Lancet, 336, 119.
3. Bishop E. H. (1964) Pelvic scoring for elective induction. Obstetrics and Gynecology, 24, 266 – 268.
4. Browning J. J., Bidgood K. A., Calder A. A., et al. (1995) Propess PMS study: post-marketing surveillance study of the efficacy and safety of ‘Propess' when administered for the induction of labour at 16 UK centres. Data on file: Ferring Pharmaceuticals Ltd., U.K.
5. Bryman I., Lindblom B. and Norstrom A. (1982) Extreme sensitivity of cervical musculature to prostaglandin E2 in early pregnancy. Lancet, ii, 1471.
6. Calder A. A. and Johnston T. A. (1995a) Cervical ripening in nulliparae: release of prostaglandin E2 from ‘Propess' and efficacy and safety in the induction of labour. In: Propess-RSA Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 1 – 4. Hasle-mere, Euromed.
7. Calder A. A. and Johnston T. A. (1995b) Assessment of pessary retrieval tape: Evaluation of the use of an attached cord to facilitate the removal of a placebo hydrogel pessary from the posterior fornix of the vagina., pp. 27 – 28.
8. Come Ili R., Cristofori P. and Terron A. (1988) Hydrogel: 4 week oral toxicity study in beagle dogs, Glaxo Group Research Limited Report No. VTX/88/014, Glaxo Group Limited, Ware, Hertfordshire, England.
9. Dollery, C., editor (1992) Dinoprostone. In: Therapeutic Drugs, pp. D159-D164. Edinburgh, Churchill Livingstone.
10. Elliot P. H. (1984) Twenty-eight day dietary toxicity study in rats with non-biodegradable polyurethane hydrogel. HRC Report No. NRD 10 ST/84574, Huntingdon Research Centre plc, Huntingdon, England.
11. Embrey M. P. and MacKenzie I. Z. (1985) Labour induc-tion with a sustained release prostaglandin E2 polymer vaginal pessary. Journal of Obstetrics and Gynaecology, 6, 38 – 41.
12. Embrey M. P., Graham N. B. and McNeill M. E. (1980) Induction of labour with a sustained-release prostaglandin E2 vaginal pessary. British Medical Jour-nal, 281, 900 – 902.
13. Greer I. A., McLaren M. and Calder A. A. (1990) Vaginal administration of PGE2 for induction of labour stimulates endogenous PGF2c, production. Acta Obstetricia et Gyne-cologica Scandinavica, 69, 621 – 625.
14. Holland K. T. (1993) Toxic shock syndrome in vitro screening of the prostaglandin pessary in the retrieval system. Data on File: Ferring Pharmaceuticals Ltd., U.K.
15. Johnston T. A. and Calder A. A. (1995) Cervical ripening in multiparae: release of prostaglandin E2 from ‘Propess' and efficacy and safety in the induction of labour. In: Propess-RS —A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 5 – 9. Haslemere, Euromed.
16. Johnston T. A., Greer I. A., Kelly R. W. and Calder A. A. (1992) The effect of pH on the release of PGE2 from vaginal and endocervical preparations for induction of labour: an in vitro study. British Journal of Obstetrics and Gynaecology, 99, 877 – 880.
17. Khouzam M. N. and Ledward R. S. (1990) Difficulties with controlled release prostaglandin E2 pessaries. Lancet, 336, 119.
18. Kynoch S. R., Charnley B. N. and Heywood R. (1983) Intramuscular implantation tests in rabbits with non-biodegradable polymer polyurethane hydrogel. Ref: PEO 7350/0. 75 HT/13 M. HRC Report No. 83336D/NRD 5/AC, and Ref: PEO 4360/1 HT. HRC Report No. 83337D/NRD 5/AC. Huntingdon Research Centre plc, Huntingdon, England.
19. MacDonald I. A. and Weir R. F. (1993) The effect of pH on release of PGE2 from vaginal and endocervical prepa-rations for induction of labour. British Journal of Obstet-rics and Gynaecology, 100, 1066 – 1067.
20. MacKenzie I. Z. (1995a) Induction of cervical ripening: Evaluation of the prostaglandin E2 release from ‘Propess' and clinical efficacy and safety in the induction of labour in women with unfavourable and partially favourable cervix. In: Propess-RS —A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 11 – 15. Haslemere, Euromed.
21. MacKenzie I. Z. (1995b) Comparison with Witepsol-based PGE2: Comparative study of prostaglandin E2 adminis-tered via ‘Propess' or a Witepsol pessary for the induc-tion of labour. Propess-RS —A Clinical Review, pp. 21 – 25.
22. MacKenzie I. Z. and Embrey M. P. (1977) Cervical ripen-ing with intravaginal prostaglandin E2 gel. British Medi-cal Journal, 2, 1381 – 1384.
23. MacKenzie I. Z. and Boland J. (1993) Current therapeutic uses of prostaglandins in obstetrics in the United King-dom. Contemporary Reviews of Obstetrics and Gynae-cology, 5, 1 – 14.
24. MacKenzie I. Z. and McKinlay E. (1995) Paediatric fol-low-up study: Follow-up of infants delivered by spon-taneous vaginal delivery, following prostaglandin E2 or oxytocin induction, or by caesarean section. In: Propess-RS — A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 37 – 39. Hasle-mere, Euromed.
25. Miller A. M., Rayburn W. F. and Smith C. V. (1991) Patterns of urine activity after intravaginal prostaglandin E2 during preinduction cervical ripening. American Jour-nal of Obstetrics and Gynecology, 165, 1006 – 1009.
26. Mowat K. J., Carty M. J. and Chatfield W. R. (1995) Propess-RS PMS study. Post-marketing surveillance study of the efficacy, acceptability and safety of ‘Propess-RS' at three UK centres. Data on File: Ferring Pharmaceuticals Ltd., U.K.
27. Novy M. J. and Liggins G. C. (1980) Role of prostaglandins, prostacycline and thromboxanes in the physiologic control of the uterus and in parturition. Seminars in Perinatology, 4, 45 – 66.
28. Rayburn W. F., Spitzberg E. and Wapner R. J. (1991) Data on File: Ferring Pharmaceuticals Ltd., U.K.
29. Rayburn W. F., Wapner R. J., Barss V. A., Spitzberg E., Molina R. D., Mandsager N. and Yonekura M. L. (1992) An intravaginal controlled release prostaglandin E2 pes-sary for cervical ripening and initiation of labour at term. Obstetrics and Gynecology, 79, 374 – 379.
30. Saulter J. (1995) Review of studies with 0.8 mm pessary: Efficacy and safety of a 0.8 mm controlled release prostaglandin E2 pessary. In: Propess-RS —A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 41 – 47. Haslemere, Euromed.
31. Shepherd J., Pearce J. M. F. and Sims C. D. (1979) Induction of labour using prostaglandin E2 pessaries. British Medical Journal, ii, 108 – 110.
32. Smith C. V., Rayburn W. F. and Miller A. M. (1994) Intravaginal prostaglandin E2 for cervical ripening and initiation of labour: Comparison of a multidose gel and single, controlled release pessary. Journal of Repro-ductive Medicine, 39, 381 – 386.
33. Taylor A. V. G. and MacKenzie I. Z. (1993) The effect of pH on the release of PGE2 from vaginal and endocervical preparations for induction of labour. British Journal of Obstetrics and Gynaecology, 100, 500 – 501.
34. Taylor A. V. G., Boland J. and MacKenzie I. Z. (1990) The concurrent in vitro and in vivo release of PGE2 from a controlled release hydrogel polymer pessary for cervical ripening. Prostaglandins, 40, 89 – 98.
35. Taylor A. V. G., Boland J., Bernal A. L. and MacKenzie I. Z. (1991) Prostaglandin metabolite levels during cervical ripening with a controlled release hydrogel polymer prostaglandin E2 pessary. Prostaglandins, 41, 585 – 594.
36. Taylor A. V. G., Boland J. and MacKenzie I. Z. (1995) Extended induction: comparison of the safety and efficacy of a second ‘Propess' pessary compared with oxytocin. In: Propess-RS —A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. Mackenzie, pp. 17 – 20. Haslemere, Euromed.
37. Westgate J. and Williams J. A. (1994) Evaluation of a controlled release vaginal prostaglandin E2 pessary with a retrieval system for the induction of labour. Journal of Obstetrics and Gynaecology, 14, 146 – 150.
38. Westgate J. and Williams J. A. (1995) Evaluation of ‘Propess-RS': Evaluation of the efficacy, safety and con-venience of ‘Propess-RS' in the induction of labour. In: Propess-RS —A Clinical Review, edited by A. A. Calder, M. J. N. C. Keirse and I. Z. MacKenzie, pp. 29 – 35. Haslemere, Euromed.
39. Witter F. R., Rocco L. E. and Johnson T. R. B. (1992) A randomized trial of prostaglandin E2 in a controlled release vaginal pessary for cervical ripening at term. American Journal of Obstetrics and Gynecology, 166, 830 – 834.